Abstract:Background: To investigate the diagnostic performance of simultaneous 18F-fluoro-deoxyglucose ([18F]-FDG) PET/MR enterography in assessing and grading endoscopically active inflammation in patients with ulcerative colitis. Methods: 50 patients underwent PET/MR 24 h before ileocolonoscopy. Inflammatory activities of bowel segments were evaluated with both Mayo endoscopic subscore and Nancy histologic index. MR, DWI (Diffusion-weighted imaging) and PET were utilized as qualitative parameters for detecting endoscopically active inflammation. SUVmaxQuot in each segment (maximum of standard uptake value relative to liver) was calculated to quantify inflammation. Results: In the study arm without bowel purgation, combined reading of PET and MR resulted in significantly increased specificity against each submodality alone (0.944 vs. 0.82 for MR and 0.843 for PET, p < 0.05) and highest overall accuracy. In the study arm with bowel purgation, the significantly lower specificity of PET (0.595) could be markedly improved by a combined reading of PET and MR. Metabolic conditions in bowel segments with both endoscopic and histological remission were significantly lower than in segments with endoscopic remission but persistent microscopic inflammation (SUVmaxQuot 0.719 vs. 0.947, p < 0.001). SUVmaxQuot correlated highly with Mayo endoscopic subscore (ρ = 0.718 and 0.606) and enabled grading of inflammatory activity. Conclusions: Simultaneous [18F]-FDG PET/MR may be considered as an alternative to endoscopy in clinical trials.

What problem does this paper attempt to address?

This paper attempts to address the issue of evaluating the diagnostic performance of concurrent 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography/magnetic resonance imaging (PET/MR) in detecting endoscopic active inflammation in patients with Ulcerative Colitis (UC), and exploring its potential application in clinical trials. ### Specific Issues Include: 1. **Evaluating Endoscopic Active Inflammation**: The study aims to assess the diagnostic performance of 18F-FDG PET/MR in detecting endoscopic active inflammation in UC patients, particularly whether the combined use of PET and MR can improve diagnostic accuracy compared to using MRI, DWI (diffusion-weighted imaging), or PET alone. 2. **Grading Inflammatory Activity**: The study also explores whether SUVmaxQuot (maximum standardized uptake value relative to the liver's maximum value) can be used to grade inflammatory activity and analyze its correlation with the Mayo endoscopic score. 3. **Predicting Complete Remission**: The study further investigates the performance of SUVmaxQuot in predicting endoscopic remission and complete remission (both endoscopic and histological remission) and defines the optimal cutoff value. 4. **Extraintestinal Manifestations**: Evaluating the value of PET/MR in detecting extraintestinal manifestations in UC patients, particularly whether these manifestations are IBD-specific and whether further clinical examination is needed. ### Research Background: - **Ulcerative Colitis**: UC is a chronic inflammatory bowel disease with a course of recurrent flare-ups and remissions. Currently, endoscopic evaluation remains the gold standard for assessing UC inflammatory activity, but it has drawbacks such as procedural discomfort, invasiveness, and low patient acceptance. - **Need for Non-Invasive Diagnostic Methods**: Therefore, finding reliable non-invasive diagnostic methods is of great significance for clinical trials and practice. In recent years, 18F-FDG PET/MR has shown superior diagnostic performance in evaluating IBD. ### Research Objectives: - **Validate the Diagnostic Performance of 18F-FDG PET/MR**: Through a prospective study, validate the diagnostic performance of 18F-FDG PET/MR in detecting endoscopic active inflammation in UC patients, particularly the diagnostic advantages of the combined use of PET and MR. - **Explore the Application of SUVmaxQuot**: Investigate the potential application of SUVmaxQuot in assessing inflammatory activity and predicting complete remission. - **Evaluate Extraintestinal Manifestations**: Assess the value of PET/MR in detecting extraintestinal manifestations in UC patients. By addressing these issues, the study hopes to provide a new, reliable alternative method for the non-invasive diagnosis of UC.

Diagnostic Performance of Simultaneous [18F]-FDG PET/MR for Assessing Endoscopically Active Inflammation in Patients with Ulcerative Colitis: A Prospective Study